All the news Showing 10 of 12 articles from: New and experimental treatments for hepatitis BGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Major hep B players Gilead and Vir join forces to find a cure Fierce Biotech / 18 January 2021 Phase 1 clinical study begins for VTP-300 Immunotherapeutic for Hepatitis B patients Express Healthcare / 14 July 2020 Assembly Biosciences Initiates Phase 2 Trial Evaluating Second-Generation Core Inhibitor ABI-H2158 for Chronic Hepatitis B Infection Assembly Biosciences press release / 14 July 2020 Gilead axes $445M Precision Biosciences gene therapy hep B pact Fierce Biotech / 14 July 2020 Vir's hep B drug, poised for combo trials, shows promise in phase 2 Fierce Biotech / 28 April 2020 Hepatitis B Foundation Plans Externally-Led Patient-Focused Drug Development Meeting for Chronic Hepatitis B in June 2020 Hepatitis B Foundation / 11 December 2019 Roche takes aim at hepatitis B, striking R&D deal with Dicerna Biopharma Dive / 12 November 2019 Arbutus cans early-phase hep B program after 2 healthy people fall ill Fierce Biotech / 24 October 2019 New Tenofovir Formulation Provides Safer Hepatitis B Treatment Medscape (free registration required) / 03 October 2016 Johnson and Johnson acquires Novira to expand HBV pipeline Healio Hepatology / 11 November 2015 ← First12Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Noticeboard Email bulletins News feeds